Search Results - "Arvelakis, Antonios"

Refine Results
  1. 1

    Comparison of monopolar electrocoagulation, bipolar electrocoagulation, Ultracision, and Ligasure by Diamantis, Theodore, Kontos, Michael, Arvelakis, Antonios, Syroukis, Spiridon, Koronarchis, Dimitris, Papalois, Apostolos, Agapitos, Emmanuel, Bastounis, Elias, Lazaris, Andreas C

    Published in Surgery today (Tokyo, Japan) (01-10-2006)
    “…Hemostasis is a fundamental principle of surgery. We compared the safety and efficacy of monopolar electrocoagulation (ME), bipolar electrocoagulation (BE),…”
    Get full text
    Journal Article
  2. 2
  3. 3
  4. 4

    Living Donor Nephrectomy Using a Right Malrotated Kidney: A Case Report by Bekki, Yuki, Arvelakis, Antonios, Florman, Sander, Shapiro, Ron

    Published in Transplantation proceedings (01-05-2021)
    “…A 46-year-old woman was approved as a living kidney donor in our center for paired donation working with the National Kidney Registry. The imaging revealed a…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Is obesity a contraindication for kidney donation? by Schussler, Lilli, Khetan, Prerna, Peacock, Matthew, Dickstein, Elisha, LaPointe-Rudow, Dianne, Palese, Michael, Arvelakis, Antonios, Herron, Daniel, Shapiro, Ron, Florman, Sander, Chin, Edward H.

    Published in Surgical endoscopy (01-10-2020)
    “…Introduction To enlarge the donor pool, kidney donors with obesity have been considered. We hypothesized that it is safe for patients with obesity to serve as…”
    Get full text
    Journal Article
  7. 7

    Asystolic donor warm ischemia time is associated with development of postreperfusion syndrome in donation after circulatory death liver transplant by Bekki, Yuki, Rocha, Chiara, Myers, Bryan, Wang, Ryan, Smith, Natalie, Tabrizian, Parissa, DiNorcia, Joseph, Moon, Jang, Arvelakis, Antonios, Facciuto, Marcelo E., DeMaria, Samuel, Florman, Sander

    Published in Clinical transplantation (01-05-2024)
    “…Background Individual events during donation after circulatory death (DCD) procurement, such as hypotensive or hypoxic warm ischemia, or circulatory arrest are…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Postreperfusion syndrome in liver transplantation: Outcomes, predictors, and application for recipient selection by Bekki, Yuki, Myers, Bryan, Wang, Ryan, Smith, Natalie, Zerillo, Jeron, Rocha, Chiara, Tabrizian, Parissa, Moon, Jang, Arvelakis, Antonios, Facciuto, Marcelo E., DeMaria, Samuel, Florman, Sander

    Published in Clinical transplantation (01-04-2022)
    “…Background This study aimed to identify risk factors for postreperfusion syndrome (PRS) and its impact on LT outcomes. Methods Data analysis was performed in…”
    Get full text
    Journal Article
  10. 10

    Increasing living donation by implementing the Kidney Coach Program by LaPointe Rudow, Dianne, Geatrakas, Sara, Armenti, Jonathan, Tomback, Ariella, Khaim, Rafael, Porcello, Lisa, Pan, Stephanie, Arvelakis, Antonios, Shapiro, Ron

    Published in Clinical transplantation (01-02-2019)
    “…Candidates for living donor kidney transplantation (LDKT) find it difficult to discuss living donation with people in their social network, and there is a lack…”
    Get full text
    Journal Article
  11. 11

    Different outcomes after kidney transplantation between African Americans and Whites: A matter of income? A single‐center study by Arvelakis, Antonios, Lerner, Susan, Wadhera, Vikram, Delaney, Veronica, Ames, Scott, Benvenisty, Alan, Sehgal, Vinita, Bhansali, Arjun, De Boccardo, Graciela, Sun, Eric, Florman, Sander, Shapiro, Ron

    Published in Clinical transplantation (01-11-2019)
    “…Background Our center has one of the largest representations of African Americans in listed and transplanted patients. We investigated if and how racial…”
    Get full text
    Journal Article
  12. 12

    Segmental grafts in adult and pediatric liver transplantation: improving outcomes by minimizing vascular complications by Rodriguez-Davalos, Manuel I, Arvelakis, Antonios, Umman, Veysel, Tanjavur, Vijayakumar, Yoo, Peter S, Kulkarni, Sanjay, Luczycki, Stephen M, Schilsky, Michael, Emre, Sukru

    Published in JAMA surgery (01-01-2014)
    “…The use of technically variant segmental grafts are key in offering transplantation to increase organ availability. To describe the use of segmental allograft…”
    Get more information
    Journal Article
  13. 13
  14. 14

    Use of model for end‐stage liver disease exception points for early liver transplantation and successful reversal of hepatic myelopathy with a review of the literature by Caldwell, Cary, Werdiger, Norman, Jakab, Sofia, Schilsky, Michael, Arvelakis, Antonios, Kulkarni, Sanjay, Emre, Sukru

    Published in Liver transplantation (01-07-2010)
    “…Hepatic myelopathy (HM) is a rarely reported disorder characterized by progressive spastic paraparesis due to impaired corticospinal tract function in the…”
    Get full text
    Journal Article
  15. 15

    Robotic-assisted vs. laparoscopic donor nephrectomy: a retrospective comparison of perioperative course and postoperative outcome after 1 year by Yang, Anthony, Barman, Naman, Chin, Edward, Herron, Daniel, Arvelakis, Antonios, LaPointe Rudow, Dianne, Florman, Sander S., Palese, Michael A.

    Published in Journal of robotic surgery (01-06-2018)
    “…Safety is of utmost importance in live donor nephrectomies. In this study, we describe our initial experience with robot-assisted laparoscopic donor…”
    Get full text
    Journal Article
  16. 16

    Renal Safety of Intravenous Ketorolac Use After Donor Nephrectomy by Tabrizian, Parissa, Giacca, Massimo, Prigoff, Jake, Tran, Benjamin, Holzner, Matthew L., Chin, Edward, Palese, Michael, Herron, Daniel, Arvelakis, Antonios, Rudow, Dianne LaPointe, Florman, Sander, Shapiro, Ron

    “…Introduction: The benefit and short-term safety of ketorolac have been established in previous studies however, the risk of bleeding and long-term renal…”
    Get full text
    Journal Article
  17. 17

    Liver transplantation for neonatal hemochromatosis: Analysis of the UNOS database by Sheflin-Findling, Shari, Annunziato, Rachel A., Chu, Jaime, Arvelakis, Antonios, Mahon, Danielle, Arnon, Ronen

    Published in Pediatric transplantation (01-03-2015)
    “…NH is the most common identifiable cause of ALF in the neonate. LT is the definitive treatment for neonates with NH who have failed medical therapy. Our aim…”
    Get full text
    Journal Article
  18. 18

    Early conversion to belatacept after renal transplantation by Nair, Vinay, Liriano‐Ward, Luz, Kent, Rebecca, Huprikar, Shirish, Rana, Mena, Florman, Sander S., Delaney, Veronica B., Menon, Madhav C., Sehgal, Vinita, Miko, Leandra, Khaim, Rafael, Benvenisty, Alan, Lerner, Susan, Arvelakis, Antonios, Wadhera, Vikram, Ames, Scott, Shapiro, Ron

    Published in Clinical transplantation (01-05-2017)
    “…Belatacept is a non‐nephrotoxic immunosuppressive agent, which may make it the ideal agent for patients with delayed or slow graft function on calcineurin…”
    Get full text
    Journal Article
  19. 19
  20. 20

    The arbitrary magic of p<0.05: Beyond statistics by E Alifieris, Constantinos, Souferi Chronopoulou, Eleni, T Trafalis, Dimitrios, Arvelakis, Antonios

    “…Modern research and scientific conclusions are widely regarded as valid when the study design and analysis are interpreted correctly. P-value is considered to…”
    Get more information
    Journal Article